Newcastle disease virus vector-based SARS-CoV-2 vaccine candidate AVX/COVID-12 activates T cells and is recognized by antibodies from COVID-19 patients and vaccinated individualsImmunology Original Research Published on 2024-05-302024-09-05 Journal: Frontiers in immunology [Category] update2024, [키워드] Antibody responses antigenicity COVID19 newcastle disease virus T cell responses Vaccines [DOI] 10.3389/fimmu.2024.1394114 PMC 바로가기 [Article Type] Immunology Original Research
Nine-Month Trend of IgG Antibody Persistence and Associated Symptoms Post-SARS-CoV-2 InfectionArticle Published on 2024-05-052024-09-05 Journal: International journal for equity in health [Category] update2024, [키워드] Antibody responses COVID-19 reinfection COVID-19 serological testing SARS-CoV-2 infection antibody testing Seroconversion [DOI] 10.3390/healthcare12090948 PMC 바로가기 [Article Type] Article
Potential determinants of antibody responses after vaccination against SARS-CoV-2 in older persons: the Doetinchem Cohort Studyarticle Published on 2023-10-252024-09-05 Journal: Immunity & Ageing : I & A [Category] update2024, [키워드] age Antibody responses Comorbidity COVID-19 vaccination frailty Lifestyle deficits [DOI] 10.1186/s12979-023-00382-4 PMC 바로가기 [Article Type] article
An update on studies characterizing adaptive immune responses in SARS-CoV-2 infection and COVID-19 vaccinationInvited Review Published on 2023-08-062024-09-05 Journal: International Immunology [Category] update2024, [키워드] Antibody responses correlates of protection pre-existing memory T cell variants [DOI] 10.1093/intimm/dxad014 PMC 바로가기 [Article Type] Invited Review
Humoral immune responses associated with control of SARS-CoV-2 breakthrough infections in a vaccinated US military populationArticle Published on 2023-07-042024-09-05 Journal: eBioMedicine [Category] update2024, [키워드] Antibody responses Breakthrough infection duration COVID-19 vaccine SARS-CoV-2 [DOI] 10.1016/j.ebiom.2023.104683 PMC 바로가기 [Article Type] Article
Validation of dried blood spot sampling for detecting SARS-CoV-2 antibodies and total immunoglobulins in a large cohort of asymptomatic young adultsArticle Published on 2023-05-162024-09-05 Journal: Journal of Immunological Methods [Category] update2024, [키워드] Antibody responses dried blood spot ELISA SARS-CoV-2 [DOI] 10.1016/j.jim.2023.113492 PMC 바로가기 [Article Type] Article
Fc-mediated pan-sarbecovirus protection after alphavirus vector vaccinationArticle Published on 2023-03-302024-09-05 Journal: Cell Reports [Category] update2024, [키워드] animal model Antibody responses coronavirus correlates of protection cross-protection FcR effector function pan-coronavirus vaccine sarbecovirus systems serology Vaccine development [DOI] 10.1016/j.celrep.2023.112326 PMC 바로가기 [Article Type] Article
A systems immunology study comparing innate and adaptive immune responses in adults to COVID-19 mRNA and adenovirus vectored vaccinesArticle Published on 2023-02-172024-09-05 Journal: Cell Reports Medicine [Category] update2024, [키워드] Antibody responses COVID-19 vaccine Cytokines Immunophenotyping Lipidomics proteomics RNA-Seq SARS-CoV-2 T cell vaccination [DOI] 10.1016/j.xcrm.2023.100971 PMC 바로가기 [Article Type] Article
Reduced T-cell response following a third dose of SARS-CoV-2 vaccine in infection-naïve people living with HIVArticle Published on 2022-12-012023-07-10 Journal: The Journal of Infection [Category] COVID19(2023년), [키워드] Antibody responses Breakthrough infection cellular COVID-19 vaccine HIV humoral immune response neutralisation omicron people living with HIV SARS-CoV-2 mRNA vaccine third dose [DOI] 10.1016/j.jinf.2022.09.006 PMC 바로가기
Comparison of antibody response durability of mRNA-1273, BNT162b2, and Ad26.COV2.S SARS-CoV-2 vaccines in healthcare workersArticle Published on 2022-10-012022-11-15 Journal: International Journal of Infectious Diseases [Category] COVID19(2023년), SARS, 진단, [키워드] Ad26.COV2.S Administered age analysis of variance Anti-spike anti-spike antibody antibody level Antibody Response Antibody responses blood draws BNT162b2 BNT162b2 vaccine booster dose COVID-19 COVID-19 infection COVID-19 vaccination COVID-19 vaccinations Effectiveness enzyme-linked immunosorbent female group healthcare worker Immunosuppression interquartile range IQR Linear regression median mRNA-1273 mRNA-1273 vaccine neutralizing antibody outcome participant Participants Primary outcome SARS-CoV-2 SARS-CoV-2 vaccine significantly significantly higher vaccination Vaccine vaccine effectiveness variable [DOI] 10.1016/j.ijid.2022.08.022 PMC 바로가기